The Potential Role of Nanotechnology in Therapeutic Approaches for Triple Negative Breast Cancer.
- Published in:
- Pharmaceutics, 2013, v. 5, n. 2, p. 353, doi. 10.3390/pharmaceutics5020353
- By:
- Publication type:
- Article
Works matching IS 19994923 AND DT 2013 AND VI 5 AND IP 2
Results: 9
1
2
Polysaccharide-Based Micelles for Drug Delivery.
- Published in:
- Pharmaceutics, 2013, v. 5, n. 2, p. 329, doi. 10.3390/pharmaceutics5020329
- By:
- Publication type:
- Article
3
Design and Exploratory Neuropharmacological Evaluation of Novel Thyrotropin-Releasing Hormone Analogs and Their Brain-Targeting Bioprecursor Prodrugs.
- Published in:
- Pharmaceutics, 2013, v. 5, n. 2, p. 318, doi. 10.3390/pharmaceutics5020318
- By:
- Publication type:
- Article
4
Delivery of Cancer Therapeutics Using Nanotechnology.
- Published in:
- Pharmaceutics, 2013, v. 5, n. 2, p. 294, doi. 10.3390/pharmaceutics5020294
- By:
- Publication type:
- Article
5
Encapsulation of Hydrocortisone and Mesalazine in Zein Microparticles.
- Published in:
- Pharmaceutics, 2013, v. 5, n. 2, p. 277, doi. 10.3390/pharmaceutics5020277
- By:
- Publication type:
- Article
6
Preclinical Absorption, Distribution, Metabolism, and Excretion of an Oral Amide Prodrug of Gemcitabine Designed to Deliver Prolonged Systemic Exposure.
- Published in:
- Pharmaceutics, 2013, v. 5, n. 2, p. 261, doi. 10.3390/pharmaceutics5020261
- By:
- Publication type:
- Article
7
Development of a Novel Lipophilic, Magnetic Nanoparticle for in Vivo Drug Delivery.
- Published in:
- Pharmaceutics, 2013, v. 5, n. 2, p. 246, doi. 10.3390/pharmaceutics5020246
- By:
- Publication type:
- Article
8
Design, Synthesis and in Vitro Degradation of a Novel Co-Drug for the Treatment of Psoriasis.
- Published in:
- Pharmaceutics, 2013, v. 5, n. 2, p. 232, doi. 10.3390/pharmaceutics5020232
- By:
- Publication type:
- Article
9
Glutathione Transferase (GST)-Activated Prodrugs.
- Published in:
- Pharmaceutics, 2013, v. 5, n. 2, p. 220, doi. 10.3390/pharmaceutics5020220
- By:
- Publication type:
- Article